What makes cannabis use disorder treatment work: motivation, coping skills, self-efficacy, and therapeutic relationship

A scoping review found successful CUD treatment depends on duration, motivation enhancement, coping skills, self-efficacy, and therapeutic alliance, while sex, ethnicity, age, and comorbidities predict who benefits most.

Feingold, Daniel et al.·European archives of psychiatry and clinical neuroscience·2025·Moderate EvidenceScoping Review
RTHC-06445Scoping ReviewModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Scoping Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Specific mediators: treatment duration, motivation to change, coping skills, self-efficacy, multi-component integration. Common mediators: therapeutic alliance, empathy, expectations, cultural adaptation. Moderators: sex, ethnicity, age, comorbid disorders.

Key Numbers

CUD is the most common first-time drug treatment in EU. Mediators: duration, motivation, coping, self-efficacy. Common factors: alliance, empathy, expectations. Moderators: sex, ethnicity, age, comorbidity.

How They Did This

Scoping review of empirically evaluated studies using defined cannabis-related outcome measures, categorizing factors as mediators or moderators.

Why This Research Matters

CUD is the most common first-time drug treatment reason in the EU. Understanding why some treatments work for some people enables precision-matched care.

The Bigger Picture

Identifying what works and for whom in CUD treatment enables a precision medicine approach to addiction care.

What This Study Doesn't Tell Us

Scoping methodology is broader than systematic review. Heterogeneous studies. Mostly Western, high-income country research.

Questions This Raises

  • ?Can treatment be personalized in real-world settings?
  • ?Which mediator combinations produce best outcomes?

Trust & Context

Key Stat:
CUD is now the most common first-time drug treatment reason in the EU
Evidence Grade:
Scoping review provides broad overview but lacks systematic rigor and meta-analytic precision.
Study Age:
Published in 2025.
Original Title:
Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature.
Published In:
European archives of psychiatry and clinical neuroscience, 275(2), 341-353 (2025)
Database ID:
RTHC-06445

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Maps out the available research on a broad question.

What do these levels mean? →

Frequently Asked Questions

What makes cannabis addiction treatment effective?

Key ingredients include sufficient duration, building motivation, learning coping skills, developing self-efficacy, and a good therapeutic relationship.

Does the same treatment work for everyone?

No. Sex, ethnicity, age, and comorbid conditions all predict who benefits from which treatments.

Read More on RethinkTHC

Cite This Study

RTHC-06445·https://rethinkthc.com/research/RTHC-06445

APA

Feingold, Daniel; Tzur Bitan, Dana; Ferri, Marica; Hoch, Eva. (2025). Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature.. European archives of psychiatry and clinical neuroscience, 275(2), 341-353. https://doi.org/10.1007/s00406-024-01781-4

MLA

Feingold, Daniel, et al. "Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature.." European archives of psychiatry and clinical neuroscience, 2025. https://doi.org/10.1007/s00406-024-01781-4

RethinkTHC

RethinkTHC Research Database. "Predictors of effective therapy among individuals with Canna..." RTHC-06445. Retrieved from https://rethinkthc.com/research/feingold-2025-predictors-of-effective-therapy

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.